cas 90213-66-4|| where to buy 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

Nombre del producto:2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

IUPAC Name:2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

Unidad de embalaje	Stock disponible	Precio($)
CM103618-100g	in stock	ǜƎ
CM103618-500g	in stock	ŵŵȡ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 90213-66-4 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :90213-66-4; Fórmula molecular:C6H3Cl2N3; Punto de fusión:-; Código de sonrisas:ClC1=NC(Cl)=C2C=CNC2=N1; Densidad:

: Número de catálogo:CM103618; Peso molecular:188.01; Punto de ebullición:; Nº Mdl:MFCD08059278; Almacenamiento:-20°C

: Pyrrolopyrimidines; Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.

: Capivasertib; On November 16, FDA approved Capivasertib for the treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative locally advanced or metastatic breast cancer. Capivasertib is a highly selective inhibitor targeting three AKT subtypes (AKT1/2/3), which can block signals used by cancer cells for division and growth.